2017
DOI: 10.1016/j.coi.2017.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Cancer immunotherapy: moving forward with peptide T cell vaccines

Abstract: Recent advances in cancer immunology, such as the discovery of immune checkpoint inhibitors, have validated immune cells as potential key players for effective cancer treatment. The efficacy of these therapies seems to be codependent on a tumor-reactive T lymphocyte response. For many years, numerous attempts and strategies in developing vaccines to generate tumor-reactive T cells have yielded poor results in the clinic due to suboptimal immunogenicity and the inability to overcome an immunosuppressive tumor m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
45
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 55 publications
(49 citation statements)
references
References 44 publications
1
45
0
Order By: Relevance
“…The use of peptides as vaccines takes this rationale further, as even a single protein antigen may have many epitopes, not all of which contribute to protective immunity. Peptide vaccines offer a means to formulate vaccines containing only epitopes that are capable of inducing a positive and efficient immune response . The ease of peptide synthesis makes large scale production feasible whilst also offering a cleaner vaccine preparation lacking biological contaminations commonly associated with recombinant expression or whole organism vaccines.…”
Section: Introductionmentioning
confidence: 99%
“…The use of peptides as vaccines takes this rationale further, as even a single protein antigen may have many epitopes, not all of which contribute to protective immunity. Peptide vaccines offer a means to formulate vaccines containing only epitopes that are capable of inducing a positive and efficient immune response . The ease of peptide synthesis makes large scale production feasible whilst also offering a cleaner vaccine preparation lacking biological contaminations commonly associated with recombinant expression or whole organism vaccines.…”
Section: Introductionmentioning
confidence: 99%
“…The most appropriate vaccine design requires information about the distribution of pathogen genotypes as well as HLA alleles . Through this method, more specific epitopes could be selected which can be valuable to design epitope‐based vaccines to efficiently elicit potent B and T cell responses . On the basis of these observations, we further determined the conserved regions among the vaccine and Indonesian strains.…”
Section: Discussionmentioning
confidence: 99%
“…Another way to induce a powerful immune response is via T cell‐based vaccines. Several strategies have been developed to induce specific T cell responses, including peptide‐based CD8 + T cell vaccines or CD4 + helper T cell‐targeted vaccines . Such approaches have been employed for treating cancer and chronic HBV infection .…”
Section: Immune‐based Therapies For Hevmentioning
confidence: 99%